Researchers Uncover A Hidden Repair Switch In Human Nerve Cells
Researchers at the University of Cambridge have used lab-grown human brain and spinal cord organoids to uncover how neurons lose their ability to repair damage as they mature. The findings suggest that this decline may not be completely irreversible and could potentially be targeted with future therapies.
During early development, neurons extend long fibers known as axons, which connect the brain and spinal cord and allow signals to travel throughout the nervous system. At this stage, damaged axons can regrow relatively easily. In adulthood, however, the central nervous system loses most of this regenerative capacity, which is one reason why spinal cord injuries and many neurological disorders often result in permanent disability.
Building A Miniature Human Neural Circuit
In earlier work, scientists at Cambridge created small brain organoids from human stem cells to study motor neurone disease. These miniature tissue models resembled parts of the cerebral cortex and helped researchers identify early molecular changes associated with neurodegeneration.
For the new study, published in Cell Reports, the team developed separate brain and spinal cord organoids and allowed axons from the brain tissue to grow across a gap and connect with spinal cord tissue. The resulting network became sufficiently complex to trigger contractions in miniature muscle bundles, effectively mimicking a simplified movement circuit.
The organoids were maintained in laboratory conditions for more than a year, allowing researchers to observe how human neurons change as they mature. This provided a rare opportunity to study aspects of human nervous system development that cannot be directly observed in embryos or fetuses.
When Regeneration Stops
To investigate how regenerative ability changes over time, the researchers repeatedly injured axons at different developmental stages.
They discovered that neurons retained the ability to regrow long axons until approximately day 150 of development, roughly corresponding to the middle stages of pregnancy. After that point, regenerative capacity declined dramatically.
Younger neurons readily produced new axons following injury, while older neurons showed little or no regrowth. The findings suggest that the loss of regenerative ability is not simply a consequence of aging or damage but appears to be actively programmed into neurons as they mature.
Further analysis identified a network of genes that acts like a biological switch, gradually restricting axon growth as neurons establish stable connections. Several key genes within this network were found to suppress regeneration once development reaches a certain stage.
Existing Drug Reveals Hidden Repair Potential
The researchers then explored whether this developmental switch could be reversed.
When they experimentally blocked central regulators within the gene network, mature neurons unexpectedly regained the ability to extend new axons. This finding suggests that adult human neurons may retain a dormant regenerative capacity that can potentially be reactivated.
To identify practical ways of influencing these pathways, the team screened databases of existing medicines. One compound that emerged was lynestrenol, a synthetic hormone currently used in some contraceptive and menstrual treatments.
In laboratory experiments, lynestrenol enhanced axon regrowth following injury. Researchers emphasize that the drug itself is unlikely to become a direct treatment for spinal cord damage, but its effects provide proof of principle that medications may be capable of restoring regenerative potential in mature human neurons.
The scientists also note that real-world nerve injuries involve additional challenges, including scar tissue formation, inflammation and molecules that actively inhibit regeneration. Nevertheless, identifying neuron-specific mechanisms remains an important step toward future therapies that may combine drugs, rehabilitation strategies and biomaterials.
Organoids Helping Bridge The Gap Between Laboratory And Clinic
Much of what scientists currently know about nerve regeneration comes from studies in rodents. However, animal neurons often show a greater capacity for repair than human nerve cells, making it difficult to translate promising findings into successful treatments.
Human stem cell-derived organoids provide a valuable alternative by recreating key aspects of human nervous system biology in the laboratory. Researchers believe these models could improve the accuracy of preclinical testing while also helping reduce reliance on animal experiments.
The Cambridge team is already applying similar organoid technologies to investigate a range of other conditions, including liver regeneration, Crohn’s disease and early pregnancy development. As the technology continues to advance, organoids are expected to play an increasingly important role in personalized medicine and drug discovery.
What The Findings Could Mean
Although the research remains at an early stage, the results offer cautious optimism for conditions that currently have few treatment options, including spinal cord injury, motor neurone disease and multiple sclerosis.
By identifying when human neurons lose their ability to regenerate and uncovering mechanisms capable of reversing that process, the study opens a potential path toward therapies aimed at restoring functions that are currently considered permanently lost.
While many scientific and clinical hurdles remain, the findings suggest that the regenerative potential of human neurons may not disappear entirely—it may simply become dormant and require the right signals to be switched on again.
